Oscar Health (OSCR)
(Delayed Data from NYSE)
$17.72 USD
+0.99 (5.92%)
Updated Aug 23, 2024 04:00 PM ET
After-Market: $17.73 +0.01 (0.06%) 7:58 PM ET
3-Hold of 5 3
C Value A Growth A Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$17.72 USD
+0.99 (5.92%)
Updated Aug 23, 2024 04:00 PM ET
After-Market: $17.73 +0.01 (0.06%) 7:58 PM ET
3-Hold of 5 3
C Value A Growth A Momentum A VGM
Zacks News
Prudential (PRU) Misses Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Prudential (PRU) delivered earnings and revenue surprises of -5.84% and 1.06%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Strength Seen in Lemonade (LMND): Can Its 12.8% Jump Turn into More Strength?
by Zacks Equity Research
Lemonade (LMND) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Old Republic International (ORI) Q4 Earnings and Revenues Top Estimates
by Zacks Equity Research
Old Republic (ORI) delivered earnings and revenue surprises of 63.27% and 1.90%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Oscar Health, Inc. (OSCR) Reports Q3 Loss, Tops Revenue Estimates
by Zacks Equity Research
Oscar Health, Inc. (OSCR) delivered earnings and revenue surprises of -19.74% and 5.08%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Cigna (CI) Surpasses Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Cigna (CI) delivered earnings and revenue surprises of 5.96% and 1.10%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
American International Group (AIG) Q3 Earnings Surpass Estimates
by Zacks Equity Research
American International Group (AIG) delivered earnings and revenue surprises of 11.86% and 1.50%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
PCB Bancorp (PCB) Q3 Earnings Miss Estimates
by Zacks Equity Research
PCB Bancorp (PCB) delivered earnings and revenue surprises of -32.35% and 2.06%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Cigna (CI) & Oscar Health Boost Presence in Philadelphia
by Zacks Equity Research
Cigna (CI) & Oscar Health's plans are likely to target businesses with 1-50 employees.
Cigna (CI) Q2 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Cigna (CI) delivered earnings and revenue surprises of 14.34% and 2.73%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Trean Insurance (TIG) Surpasses Q2 Earnings Estimates
by Zacks Equity Research
Trean Insurance (TIG) delivered earnings and revenue surprises of 120% and 4.23%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
EverQuote (EVER) Reports Q2 Loss, Tops Revenue Estimates
by Zacks Equity Research
EverQuote (EVER) delivered earnings and revenue surprises of 74.47% and 7.15%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Is MetLife (MET) a Great Value Stock Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Are Investors Undervaluing Cigna (CI) Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Is MGIC Investment (MTG) a Great Value Stock Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Oscar Health, Inc. (OSCR) Reports Q1 Loss, Tops Revenue Estimates
by Zacks Equity Research
Oscar Health, Inc. (OSCR) delivered earnings and revenue surprises of 10% and 21.14%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Lemonade (LMND) Reports Q1 Loss, Tops Revenue Estimates
by Zacks Equity Research
Lemonade (LMND) delivered earnings and revenue surprises of 15.38% and 2.43%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Horace Mann (HMN) Q1 Earnings Lag Estimates
by Zacks Equity Research
Horace Mann (HMN) delivered earnings and revenue surprises of -31.91% and 2.06%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Goosehead Insurance (GSHD) Q1 Earnings Beat Estimates
by Zacks Equity Research
Goosehead (GSHD) delivered earnings and revenue surprises of 300% and 0.99%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Can Oscar Health, Inc. (OSCR) Climb 162% to Reach the Level Wall Street Analysts Expect?
by Zacks Equity Research
The consensus price target hints at a 162.4% upside potential for Oscar Health, Inc. (OSCR). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Cigna (CI), Oscar to Address Needs of Arizona's Small Businesses
by Zacks Equity Research
Cigna (CI) joins forces with Oscar Health to extend its health insurance product to small business units across Arizona.
Prudential (PRU) to Report Q1 Earnings: What's in Store?
by Zacks Equity Research
Prudential's (PRU) Q1 results are likely to reflect higher net investment spread results, business growth and higher reserve gains.
Cigna (CI), Oscar to Aid Small Business With Health Insurance
by Zacks Equity Research
Cigna (CI) along with Oscar Health rolls out a health insurance product aimed for small business units in the state of California.